Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC) Share Price

Price 114.80p on 23-10-2026 at 08:35:10
Change -1.00p -0.86%
Buy 115.20p
Sell 114.80p
Last Trade: Buy 416.00 at 114.80p
Day's Volume: 26,811
Last Close: 115.80p
Open: 114.80p
ISIN: GB00BY2Z0H74
Day's Range 114.80p - 116.00p
52wk Range: 106.60p - 142.00p
Market Capitalisation: £281.47m
VWAP: 115.41583p
Shares in Issue: 245.18m

PureTech (PRTC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 416 114.80p Automatic Execution
09:34:24 - 23-Oct-26
Buy* 8 114.80p Automatic Execution
09:34:24 - 23-Oct-26
Buy* 110 115.40p Automatic Execution
09:18:02 - 23-Oct-26
Buy* 386 115.20p Automatic Execution
09:18:02 - 23-Oct-26
Buy* 17 115.20p SI Trade
08:42:56 - 23-Oct-26
Sell* 245 114.80p Automatic Execution
08:42:56 - 23-Oct-26
Sell* 255 114.80p Automatic Execution
08:42:04 - 23-Oct-26
Buy* 3,000 115.4461p Ordinary
08:40:30 - 23-Oct-26
Sell* 1,309 115.00p Automatic Execution
08:22:12 - 23-Oct-26
Sell* 107 115.00p Automatic Execution
08:22:12 - 23-Oct-26
See more PureTech trades

PureTech (PRTC) Share Price History

Time period:
to
Date Open High Low Close Volume
22nd Oct 2026 (Thu) 116.00 116.00 113.60 115.80 148,690
21st Oct 2026 (Wed) 110.00 114.40 110.00 114.40 172,886
20th Oct 2026 (Tue) 110.00 113.80 110.00 113.80 281,792
19th Oct 2026 (Mon) 112.00 115.40 112.00 115.40 275,156
16th Oct 2026 (Fri) 112.00 115.00 112.00 114.60 935,544
15th Oct 2026 (Thu) 112.40 114.80 112.40 114.00 506,794
14th Oct 2026 (Wed) 112.60 114.20 112.40 113.80 397,574
13th Oct 2026 (Tue) 109.00 114.40 109.00 111.80 454,410
12th Oct 2026 (Mon) 112.00 114.20 112.00 112.60 547,313
9th Oct 2026 (Fri) 107.00 111.20 107.00 111.00 1,065,530
8th Oct 2026 (Thu) 112.00 112.00 108.00 108.00 1,293,295
7th Oct 2026 (Wed) 106.60 111.60 106.60 110.20 1,831,213
6th Oct 2026 (Tue) 107.00 112.20 107.00 109.00 522,484
5th Oct 2026 (Mon) 107.60 108.60 106.80 107.60 392,656
2nd Oct 2026 (Fri) 110.80 110.80 107.20 107.80 856,820
1st Oct 2026 (Thu) 115.60 115.60 110.60 110.60 411,797
30th Sep 2026 (Wed) 114.20 115.40 114.20 115.00 758,816
29th Sep 2026 (Tue) 115.00 117.60 114.20 114.20 282,712
28th Sep 2026 (Mon) 115.40 118.20 115.20 115.60 740,393
25th Sep 2026 (Fri) 116.20 117.00 114.40 114.40 651,606
24th Sep 2026 (Thu) 113.00 117.40 113.00 116.00 332,768
23rd Sep 2026 (Wed) 112.20 116.00 110.40 116.00 1,435,329
See more PureTech price history

PureTech (PRTC) Regulatory News

Date Source Headline
19th Oct 2026 7:00 am RNS-R PRTC's Gallop to Present Ph1b LYT-200 Data at ESMO
9th Oct 2026 6:00 pm RNS-R PRTC's SPTX Presents Phase 1 GlyphAgo Data at ECNP
7th Oct 2026 6:00 pm RNS-R PRTC's SPTX: Phase 2a Trial of GlyphAgo Initiated
7th Oct 2026 7:00 am RNS Holding(s) in Company
25th Sep 2026 6:13 pm RNS Holding(s) in Company
22nd Sep 2026 7:00 am RNS Half-year Report
21st Sep 2026 7:00 am RNS-R PRTC's Gallop: Positive FDA Meeting & Fast Track
18th Sep 2026 5:00 pm RNS Holding(s) in Company
9th Sep 2026 6:00 pm RNS-R PRTC's SPTX: New Positive Phase 1 GlyphAllo Data
4th Sep 2026 5:30 pm RNS Holding(s) in Company
See more PureTech regulatory news

PureTech (PRTC) Share News

IN BRIEF: PureTech Health to announce clinical trial results in Madrid

19th Oct 2026 08:56

PureTech Health PLC - Boston, Massachusetts-based biotech and pharmaceutical company - Announces results from the first phase of the clinical trial of LYT-200, which will be presented at the European Society for Medical Oncology. LYT-200 is an antibody treatment designed to help the immune system recognise and fight cancer more effectively. The presentation will take place on October 23 in Madrid. Head of Oncology at PureTech and Chief Medical Officer Aleksandra Filipovic says: "Phase 1b results provide a strong foundation for the continued development of LYT-200." Read More

TRADING UPDATES: Dillistone new strategy; Oriole Resources maiden MRE

7th Oct 2026 21:17

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

PureTech swings to first-half profit as investment gains soar

22nd Sep 2026 12:42

(Alliance News) - PureTech PLC on Tuesday hailed "significant progress" across its portfolio as it swung to a first-half profit. Read More

PureTech Health says US FDA progress provides clear path for LYT-200

21st Sep 2026 10:34

(Alliance News) - PureTech Health PLC on Monday said feedback from the US Food & Drug Administration supports the advancement of its blood cancer treatment, LYT-200. Read More

UK earnings, trading statements calendar - next 7 days

15th Sep 2026 14:30

Read More

See more PureTech news
FTSE 100 Latest
Value10,684.83
Change-40.20

Login to your account

Forgot Password?

Not Registered